Company intelligence / Profile preview

Shanghai Rebone Biomedical Technology

Shanghai, Shanghai, Chinarebone.eu ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Shanghai Rebone Biomedical Technology is a pioneer in injectable nanocalcium phosphate cements and bioactive bone graft substitutes. Its products (notably CPC/“nanocement”) are NMPA-approved and widely adopted in hospitals across China for spinal, orthopedic, and dental bone defect repair. Human use since 2000, broad clinical adoption, and regulatory recognition/awards.

Therapeutic areas: OtherRheumatology
Modalities: BiologicDeviceHydrogel-based drug delivery therapyNanoparticle (nanocement)
Industry: Implantable Medical Devices

Partnerships

East China University of Science and Technology (academic/techlicensing)Extensive collaborations with leading Chinese hospitals (clinical trials/adoption)

Beyond the preview

Go deeper on Shanghai Rebone Biomedical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Rebone Biomedical Technology.

Explore the full profile